whether a DOUBLE dose of clopidogrel (Plavix) prevents more cardiovascular events in stent patients
Experts are debating whether a DOUBLE dose of clopidogrel (Plavix) prevents more cardiovascular events in stent patients.
Up to 25% of patients don't respond well to clopidogrel's antiplatelet effects...and are at higher risk for a cardiac event.
So some prescribers order platelet function tests to identify patients who have high platelet activity despite clopidogrel therapy.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote